Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

THRX 18.72 +0.09 (0.48%)
price chart
Theravance Inc (THRX) Drops 5.35% on September 12
Theravance Inc (THRX) was one of the Russell 2000's biggest losers for September 12 as the stock slid 5.35% to $18.92, a loss of $1.07 per share.
Related articles »  
Pharma Stocks in Focus - Celsion Corporation (CLSN), Theravance Inc (THRX ...
Celsion Corporation (NASDAQ:CLSN) shares rose Thursday, after the biopharmaceutical company that develops oncology therapies released encouraging data from two studies on the company's ThermoDox in the August issue of International Journal of ...
Theravance Inc To Go Ex-Dividend on August 26th (THRX)
Theravance logo Theravance (NASDAQ:THRX) declared a quarterly dividend on Wednesday, August 6th, American Banking & Market News reports.
Why Need to Watch: Ultra Clean (NASDAQ:UCTT), Theravance Inc. (NASDAQ ...  WallStreet Scope
Related articles »  
Top News: McDonald's Corp. (NYSE:MCD), Theravance Inc. (NASDAQ:THRX ...
Sep 9 2014 Theravance Biopharma Inc (NASDAQ:TBPH) or the Company provided a product update for VIBATIV telavancin the Company s proprietary FDA approved.
Related articles »  
Biotech Losers: Synthetic Biologics Inc. (NYSEMKT:SYN), Theravance Inc ...
Synthetic Biologics, Inc. (NYSEMKT:SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced that the U.S.
Hot Stock List: Entropic Communications (NASDAQ:ENTR), CBS (NYSE:CBS ...
Theravance Inc. (NASDAQ:THRX) declared a quarterly dividend on Wednesday, August 6th, American Banking & Market News reports.
Watch List : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Theravance Inc ...
On August 21, 2014, Bradford J. Shafer indicated that he will be resigning as Senior Vice President, General Counsel and Secretary of Theravance, Inc. (NASDAQ:THRX) effective August 31, 2014 in connection with his commencement of employment with ...
Theravance (THRX), Glaxo (GSK) Report Launch of ANORO ELLIPTA in Japan
ANORO ELLIPTA has been developed under the 2002 collaboration agreement between Glaxo Group Limited and Theravance, Inc. Theravance, Inc. is obligated to make a milestone payment of $10 million (USD) to GSK following the launch of ANORO ...
News Review -Ubiquiti Networks Inc (NASDAQ:UBNT),Theravance Inc ...
Houston, TX - Sep 15, 2014 - (Techsonian) - Ubiquiti Networks Inc (NASDAQ:UBNT) released results for its fourth quarter of fiscal 2014 finished June 30, 2014.
Related articles »  
Trader's Recap: LiveDeal (NASDAQ:LIVE), Theravance Inc. (NASDAQ:THRX ...
Aug. 27, 2014 LiveDeal, Inc. (NASDAQ:LIVE) a publicly traded company that operates livedeal.com, a geo-location based mobile marketing platform that enables restaurants to publish �real-time� and �instant offers� to nearby consumers, announced that it ...